3:28 PM
 | 
Nov 27, 2013
 |  BC Extra  |  Company News

FDA committee to discuss Epi proColon 2.0

Epigenomics AG (Xetra:ECX) said FDA set a tentative date of March 25 for a meeting of its Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee to discuss...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >